Exploring the therapeutic potential of ligand-decorated nanostructured lipid carriers for targeted solid tumor therapy
Authors:
- 9 May 2025
- journal article
- review article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 678, 125687
Abstract
No abstract availableKeywords
Funding Information
- AlMaarefa University
This publication has 207 references indexed in Scilit:
- Hyaluronan Receptors as Mediators and Modulators of the Tumor MicroenvironmentAdvanced Healthcare Materials, 2022
- Ligand conjugated lipid‐based nanocarriers for cancer theranosticsBiotechnology and Bioengineering, 2022
- Surface receptor‐mediated targeted drug delivery systems for enhanced cancer treatment: A state‐of‐the‐art reviewDrug Development Research, 2020
- Experimental methods in chemical engineering: Zeta potentialThe Canadian Journal of Chemical Engineering, 2020
- Biological Relevance of RGD‐Integrin Subtype‐Specific Ligands in CancerChemBioChem, 2020
- At the Bench: Pre-clinical evidence for multiple functions of CXCR4 in cancerJournal of Leukocyte Biology, 2020
- Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizonsIUBMB Life, 2020
- Biotin in metabolism, gene expression, and human diseaseJournal of Inherited Metabolic Disease, 2019
- Emerging functions of the EGFR in cancerMolecular Oncology, 2017
- Nanoparticles in the clinicBioengineering & Translational Medicine, 2016